Hospital & Laboratory

Due to its robust connectivity to bioMérieux equipment, MYLA allows lab results to be collected, consolidated, and communicated to stakeholders in real-time.

The NTM Elite agar plate is the industrial version of the RGM medium. It enables easier and improved diagnosis compared to commonly used Acid-Fast Bacilli (AFB) culture media.

NUCLISENS easyMAG is an IVD-labeled automated system for total nucleic acid extraction from a variety of sample types and volumes. 

Gram staining is a key step in your microbiology workflow, and PREVI^® COLOR GRAM is the system to streamline it and provide timely staining results for impactful decisions.

This test gives reliable results in under 2 hours, making it the quick and easy way to control carbapenemase producers and meet diagnostic and screening challenges, improve patient management, and control healthcare associated infections.

With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS^® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them. 

The VIDAS® C. difficile GDH and TOXIN A & B (CDAB) are two complementary tests used as an aid in the diagnosis of C. difficile associated disease.

VIDAS® D-Dimer Exclusion™ II is a highly-sensitive automated D-Dimer assay. Used in conjunction with assessment of clinical pretest probability, it allows safe exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in both low and intermediate suspected outpatient risk groups in just 20 minutes.

The VIDAS^® Fertility Panel provides key diagnostic tools for the investigation of reproductive hormone dysfunctions such as precocious and delayed puberty, amenorrhea, hirsutism, hyperprolactinemia, perimenopause and menopause, hypogonadism, gynecomastia, and azoospermia.

The NEW VIDAS Lyme assays allow for independent measurements of IgG and IgM antibodies to Borrelia burgdorferi. 

VIDAS^® NEPHROCHECK^® measures urinary TIMP-2 & IGFBP-7, specific urinary biomarkers for early risk assessment of moderate to severe Acute Kidney Injury (AKI). The VIDAS^® NEPHROCHECK^® assay is intended to be used in conjunction with clinical evaluation as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) in acutely ill patients.

Fast all-in-one test kit based on blood brain biomarkers to predict absence of intracranial lesions in mild Traumatic Brain Injury patients and objectively assess the need for a head CT-scan.

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

A secure solution offering remote access, proactive maintenance, and remote updates. VILINK^® diagnoses, solves software and instrument issues, and supports your systems to enable laboratory productivity and efficiency improvements. 

VITEK^® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.